CXCL16
C-X-C motif chemokine ligand 16
Summary
Enables chemokine activity. Involved in several processes, including positive regulation of cell growth; response to tumor necrosis factor; and response to type II interferon. Located in extracellular space. Biomarker of COVID-19 and systemic scleroderma. [provided by Alliance of Genome Resources, Jul 2025]
Known Variants24 total
| rsid | Position (GRCh37) | Alleles | Class | ClinVar |
|---|---|---|---|---|
| rs186708492 | 17:4,637,332 | G/A | downstream gene variant | — |
| rs187616158 | 17:4,637,802 | T/C | downstream gene variant | — |
| rs1051009 | 17:4,637,886 | G/T | — | — |
| rs3744700 | 17:4,638,010 | T/G | downstream gene variant | — |
| rs1323081288 | 17:4,638,443 | G/A | — | likely benign |
| rs372640806 | 17:4,638,486 | G/T | — | uncertain significance |
| rs944412462 | 17:4,638,495 | C/T | — | uncertain significance |
| rs61463072 | 17:4,638,530 | G/A | — | benign |
| rs2277680 | 17:4,638,563 | G/A | missense variant | — |
| rs919875962 | 17:4,638,677 | G/C | — | uncertain significance |
| rs774689093 | 17:4,638,684 | G/A | — | uncertain significance |
| rs760892829 | 17:4,638,717 | C/T | — | uncertain significance |
| rs201243416 | 17:4,638,785 | G/A | — | likely benign |
| rs75030713 | 17:4,639,668 | G/A | regulatory region variant | — |
| rs142017034 | 17:4,639,955 | G/A | upstream gene variant | — |
| rs60894000 | 17:4,641,369 | G/C | upstream gene variant | — |
| rs149830899 | 17:4,641,742 | G/C | — | uncertain significance |
| rs2250333 | 17:4,642,069 | A/G | splice region variant | — |
| rs758903231 | 17:4,642,197 | C/T | — | uncertain significance |
| rs2304973 | 17:4,642,222 | G/A | splice region variant | — |
| rs1916269370 | 17:4,642,618 | C/A | — | uncertain significance |
| rs140866155 | 17:4,642,630 | C/T | — | uncertain significance |
| rs1442495834 | 17:4,642,663 | G/A | — | uncertain significance |
| rs75334328 | 17:4,642,683 | C/T | — | benign |
Gene information from NCBI Gene. Variant classifications from ClinVar.